Home  |  繁體  |  簡体
       
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Annual Report

 
22-09-2017
 

Announcements and Notices - Announcement Pursuant to Rule 3.8 of the Takeovers Code

22-09-2017
 

Announcements and Notices - Announcement Pursuant to Rule 3.8 of the Takeovers Code

15-09-2017
 

Announcements and Notices - Joint Announcement (1) Proposed Privatization of Bloomage Biotechnology Corporation Limited by Grand Full Development Limited by Way of A Scheme of Arrangement (under Section 86 of the Companies Law) and (2) Proposed withdrawal of Listing of the Shares of Bloomage Biotechnology Corporation Limited Despatch of Scheme Document and Option Offer Letter

 
HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd